Texas Permanent School Fund Purchases 1,317 Shares of RadNet, Inc. (NASDAQ:RDNT)

Texas Permanent School Fund increased its position in shares of RadNet, Inc. (NASDAQ:RDNTGet Rating) by 3.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 34,919 shares of the medical research company’s stock after buying an additional 1,317 shares during the quarter. Texas Permanent School Fund owned 0.06% of RadNet worth $711,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Cubist Systematic Strategies LLC boosted its position in RadNet by 180.8% during the second quarter. Cubist Systematic Strategies LLC now owns 3,443 shares of the medical research company’s stock valued at $59,000 after purchasing an additional 2,217 shares during the last quarter. First Manhattan Co. acquired a new position in RadNet during the first quarter valued at approximately $82,000. Captrust Financial Advisors boosted its position in RadNet by 54.0% during the first quarter. Captrust Financial Advisors now owns 4,123 shares of the medical research company’s stock valued at $92,000 after purchasing an additional 1,446 shares during the last quarter. Mutual of America Capital Management LLC boosted its position in RadNet by 16.7% during the second quarter. Mutual of America Capital Management LLC now owns 7,837 shares of the medical research company’s stock valued at $135,000 after purchasing an additional 1,119 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its position in RadNet by 9.6% during the second quarter. BNP Paribas Arbitrage SA now owns 13,149 shares of the medical research company’s stock valued at $227,000 after purchasing an additional 1,147 shares during the last quarter. 68.27% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on RadNet in a research report on Wednesday, October 12th. They set a “hold” rating for the company.

RadNet Stock Performance

RDNT opened at $20.00 on Friday. RadNet, Inc. has a 12-month low of $12.03 and a 12-month high of $28.22. The stock has a market cap of $1.15 billion, a price-to-earnings ratio of 166.68 and a beta of 1.54. The business has a 50 day moving average of $18.60 and a 200-day moving average of $19.35. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 1.60.

RadNet (NASDAQ:RDNTGet Rating) last released its quarterly earnings data on Wednesday, November 9th. The medical research company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.07). RadNet had a net margin of 0.56% and a return on equity of 2.98%. The business had revenue of $350.04 million during the quarter, compared to analyst estimates of $350.17 million. On average, equities research analysts expect that RadNet, Inc. will post 0.31 earnings per share for the current year.

Insider Activity

In related news, COO Norman R. Hames sold 5,000 shares of RadNet stock in a transaction that occurred on Monday, December 19th. The stock was sold at an average price of $19.45, for a total transaction of $97,250.00. Following the completion of the sale, the chief operating officer now directly owns 275,179 shares of the company’s stock, valued at approximately $5,352,231.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, COO Norman R. Hames sold 5,000 shares of RadNet stock in a transaction that occurred on Monday, December 19th. The stock was sold at an average price of $19.45, for a total transaction of $97,250.00. Following the completion of the sale, the chief operating officer now directly owns 275,179 shares of the company’s stock, valued at approximately $5,352,231.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Christine Nayoma Gordon sold 3,000 shares of RadNet stock in a transaction that occurred on Monday, December 19th. The stock was sold at an average price of $19.57, for a total value of $58,710.00. Following the sale, the director now directly owns 9,497 shares of the company’s stock, valued at $185,856.29. The disclosure for this sale can be found here. Insiders own 5.10% of the company’s stock.

RadNet Profile

(Get Rating)

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

Featured Articles

Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet, Inc. (NASDAQ:RDNTGet Rating).

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.